JP2022539585A5 - - Google Patents

Info

Publication number
JP2022539585A5
JP2022539585A5 JP2022500080A JP2022500080A JP2022539585A5 JP 2022539585 A5 JP2022539585 A5 JP 2022539585A5 JP 2022500080 A JP2022500080 A JP 2022500080A JP 2022500080 A JP2022500080 A JP 2022500080A JP 2022539585 A5 JP2022539585 A5 JP 2022539585A5
Authority
JP
Japan
Prior art keywords
polypeptide
antigen
cells
cell
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022500080A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022539585A (ja
JP7834016B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2020/051594 external-priority patent/WO2021005339A1/en
Publication of JP2022539585A publication Critical patent/JP2022539585A/ja
Publication of JP2022539585A5 publication Critical patent/JP2022539585A5/ja
Application granted granted Critical
Publication of JP7834016B2 publication Critical patent/JP7834016B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022500080A 2019-07-05 2020-07-03 新規な癌抗原及び方法 Active JP7834016B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19184742.5 2019-07-05
EP19184742 2019-07-05
PCT/GB2020/051594 WO2021005339A1 (en) 2019-07-05 2020-07-03 Novel cancer antigens and methods

Publications (3)

Publication Number Publication Date
JP2022539585A JP2022539585A (ja) 2022-09-12
JP2022539585A5 true JP2022539585A5 (cg-RX-API-DMAC7.html) 2023-07-13
JP7834016B2 JP7834016B2 (ja) 2026-03-23

Family

ID=67211535

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022500080A Active JP7834016B2 (ja) 2019-07-05 2020-07-03 新規な癌抗原及び方法

Country Status (11)

Country Link
US (1) US12680105B2 (cg-RX-API-DMAC7.html)
EP (1) EP3994156A1 (cg-RX-API-DMAC7.html)
JP (1) JP7834016B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220034039A (cg-RX-API-DMAC7.html)
CN (2) CN114174323B (cg-RX-API-DMAC7.html)
AU (1) AU2020312230A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022000133A2 (cg-RX-API-DMAC7.html)
CA (1) CA3141990A1 (cg-RX-API-DMAC7.html)
IL (1) IL289334A (cg-RX-API-DMAC7.html)
MX (1) MX2022000262A (cg-RX-API-DMAC7.html)
WO (1) WO2021005339A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119978090A (zh) 2018-10-19 2025-05-13 弗朗西斯·克里克研究所有限公司 新的癌抗原和方法
EP3994156A1 (en) 2019-07-05 2022-05-11 The Francis Crick Institute Limited Novel cancer antigens and methods
TW202241925A (zh) 2021-01-15 2022-11-01 德商英麥提克生物技術股份有限公司 用於不同類型癌症免疫治療的hla展示肽
WO2023111306A1 (en) 2021-12-17 2023-06-22 Evaxion Biotech A/S Personalized cancer therapy targeting normally non-expressed sequences
WO2025202937A1 (en) 2024-03-26 2025-10-02 BioNTech SE Cancer vaccines

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0871747A1 (en) 1996-01-02 1998-10-21 Chiron Viagene, Inc. Immunostimulation mediated by gene-modified dendritic cells
US6770456B1 (en) 1998-07-29 2004-08-03 Ludwig Institute For Cancer Research Endogenous retrovirus tumor associated nucleic acids and antigens
EP1109821A4 (en) 1998-08-25 2002-04-03 Human Genome Sciences Inc 49 HUMAN-SECRETED PROTEINS
US7504490B1 (en) 1998-10-16 2009-03-17 Oscient Pharmaceuticals Corporation Nucleic acid and amino acid sequences relating to Apergillus fumigatus for diagnostics and therapeutics
AU2001238347A1 (en) 2000-02-28 2001-09-12 Hyseq, Inc. Novel nucleic acids and polypeptides
US6436703B1 (en) 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
WO2001077330A2 (en) * 2000-04-06 2001-10-18 Pharmacia & Upjohn Company G protein-coupled receptors
US20020082206A1 (en) 2000-05-30 2002-06-27 Leach Martin D. Novel polynucleotides from atherogenic cells and polypeptides encoded thereby
US20040142325A1 (en) 2001-09-14 2004-07-22 Liat Mintz Methods and systems for annotating biomolecular sequences
US7193069B2 (en) * 2002-03-22 2007-03-20 Research Association For Biotechnology Full-length cDNA
JP2003304877A (ja) 2002-04-15 2003-10-28 Keio Gijuku ヒト色素細胞特異分子
AU2003298606A1 (en) 2002-10-25 2004-05-13 Five Prime Therapeutics, Inc. Human polypeptides encoded by polynucleotides and methods of their use
EP1586330A1 (en) 2004-04-16 2005-10-19 Georg-August-Universität Göttingen Vaccination against malignant melanoma
EP2402447A1 (en) 2005-03-30 2012-01-04 Viroxis Endogenous retrovirus and proteins encoded by env gene as a target for cancer treatment
WO2006105642A1 (en) 2005-04-05 2006-10-12 British Columbia Cancer Agency Biomarkers for the detection of lung cancer and uses thereof
AT502292B1 (de) 2005-05-11 2010-04-15 Avir Green Hills Biotechnology Melanomdiagnose
US20070072175A1 (en) 2005-05-13 2007-03-29 Biogen Idec Ma Inc. Nucleotide array containing polynucleotide probes complementary to, or fragments of, cynomolgus monkey genes and the use thereof
EP1963534A2 (en) 2005-12-19 2008-09-03 Genizon Biosciences Inc. Genemap of the human gene associated with crohn's disease
WO2007109583A2 (en) 2006-03-17 2007-09-27 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject
US20090297530A1 (en) 2006-05-22 2009-12-03 Feng Wang-Johanning Herv-k antigens, antibodies, and methods
US20080019979A1 (en) 2006-05-22 2008-01-24 Feng Wang-Johanning HERV-K Antigens, Antibodies, and Methods
EP2052088A2 (en) * 2006-08-02 2009-04-29 Genizon Biosciences Genemap of the human genes associated with psoriasis
US20100120628A1 (en) 2007-02-06 2010-05-13 Genizon Biosciences Inc. Genemap of the human genes associated with adhd
US8541553B2 (en) 2007-05-24 2013-09-24 Baxter Healthcare Sa Antibodies specific for the melanoma-associated endogenous retrovirus (MERV) envelope glycoprotein
WO2009026116A2 (en) * 2007-08-16 2009-02-26 Genizon Biosciences, Inc. Genemap of the human genes associated with longevity
WO2009039244A2 (en) 2007-09-18 2009-03-26 Genizon Biosciences Inc. Genemap of the human genes associated with crohn's disease
EP2340851A4 (en) 2008-09-18 2012-09-26 Univ Keio DIAGNOSTIC METHOD AND THERAPEUTIC METHOD FOR CANCER
HK1204482A1 (en) 2011-08-30 2015-11-20 Dcb-美国有限责任公司 Gene biomarkers for prediction of susceptibility of ovarian neoplasms and/or prognosis or malignancy of ovarian cancers
EP2771349B1 (en) 2011-09-16 2020-02-26 Iogenetics, LLC. Bioinformatic processes for determination of peptide binding
CN103813922B (zh) 2011-09-22 2016-08-17 舍弗勒技术股份两合公司 带电动机的驱动单元
FR2984362B1 (fr) 2011-12-20 2017-11-24 Biomerieux Sa Procede pour le diagnostic ou le pronostic in vitro du cancer du poumon
WO2014004385A2 (en) 2012-06-25 2014-01-03 Board Of Regents, The University Of Texas System Anti-cancer vaccines
EP2878678A1 (en) 2013-12-02 2015-06-03 Fraunhofer-Gesellschaft zur Förderung der Angewandten Forschung e.V. RNA-biomarkers for diagnosis of prostate cancer
ES2807791T3 (es) 2014-12-08 2021-02-24 Univ Michigan Regents ARN no codificantes y usos de los mismos
GB201521746D0 (en) * 2015-12-10 2016-01-27 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against CLL and other cancers
GB201521894D0 (en) * 2015-12-11 2016-01-27 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against various cancers
CR20200608A (es) * 2016-04-21 2021-01-20 Immatics Biotechnologies Gmbh INMUNOTERAPIA CONTRA EL MELANOMA Y OTROS TIPOS DE CÁNCER (Divisional 2018-0551)
US10384736B2 (en) * 2016-07-13 2019-08-20 Marcelo A. Pizarro Dual oscillating cycle saddle and support system
CA3052255A1 (en) 2017-02-01 2018-08-09 Modernatx, Inc. Rna cancer vaccines
EP3731849A4 (en) 2017-12-28 2021-12-01 Codiak BioSciences, Inc. EXOSOME FOR IMMUNONCOLOGICAL AND ANTI-INFLAMMATORY THERAPY
CN113329761A (zh) 2018-09-04 2021-08-31 特雷斯生物有限公司 肽疫苗
CN119978090A (zh) 2018-10-19 2025-05-13 弗朗西斯·克里克研究所有限公司 新的癌抗原和方法
CN118666956A (zh) 2019-06-25 2024-09-20 蒙特利尔大学 肿瘤抗原肽、肽组合、核酸、负载体、疫苗及其用途
WO2020260897A1 (en) 2019-06-28 2020-12-30 The Francis Crick Institute Limited Novel cancer antigens and methods
AU2020307943A1 (en) 2019-06-28 2021-12-02 Enara Bio Limited Novel cancer antigens and methods
EP3994156A1 (en) 2019-07-05 2022-05-11 The Francis Crick Institute Limited Novel cancer antigens and methods
MX2022000263A (es) 2019-07-05 2022-02-03 The Francis Crick Institute Ltd Nuevos antigenos y metodos contra el cancer.
EP4136097A1 (en) 2020-04-17 2023-02-22 The Francis Crick Institute Limited Fusion proteins of ctl antigens for treating melanoma
EP4136096A1 (en) 2020-04-17 2023-02-22 The Francis Crick Institute Limited Antigen pool
EP4329795A1 (en) 2021-04-28 2024-03-06 Enara Bio Limited Novel cancer antigens and methods
CN119563038A (zh) 2022-05-25 2025-03-04 旗舰创业创新七公司 用于调节免疫应答的组合物和方法
AU2024404814A1 (en) 2023-12-19 2026-07-02 Enara Bio Limited Novel cancer antigens and methods

Similar Documents

Publication Publication Date Title
JP2022540396A5 (cg-RX-API-DMAC7.html)
JP2022514116A5 (cg-RX-API-DMAC7.html)
Senovilla et al. Trial watch: DNA vaccines for cancer therapy
US20220016164A1 (en) Pharmaceutical composition for use in the treatment of pancreatic cancer
Han et al. Ferritin protein cage nanoparticles as versatile antigen delivery nanoplatforms for dendritic cell (DC)-based vaccine development
JP2022538609A5 (cg-RX-API-DMAC7.html)
Chesson et al. Antigenic peptide nanofibers elicit adjuvant-free CD8+ T cell responses
CN102947452A (zh) 使用用于癌症的辅佐治疗的李斯特菌属的方法和组合物
JP2022539157A5 (cg-RX-API-DMAC7.html)
US20230054958A1 (en) Ctl peptide epitopes and antigen-specific t cells, methods for their discovery, and uses thereof
CN106243213B (zh) 一种肿瘤相关抗原XAGE-1b短肽及应用
CN118076378A (zh) 包含肿瘤相关抗原衍生肽以及由脂肽和免疫活性物质组成的佐剂的抗癌疫苗组合物及其用途
Mesa et al. Very small size proteoliposomes derived from Neisseria meningitidis: an effective adjuvant for generation of CTL responses to peptide and protein antigens
CN109970846A (zh) 一种肿瘤相关抗原XAGE-1b九肽及其应用
JP2014139185A5 (cg-RX-API-DMAC7.html)
JP2011506497A5 (cg-RX-API-DMAC7.html)
CN106279392B (zh) 肿瘤相关抗原XAGE-1b短肽及其应用
JP2018528960A5 (cg-RX-API-DMAC7.html)
Zhu et al. Tumor antigen delivered by Salmonella III secretion protein fused with heat shock protein 70 induces protection and eradication against murine melanoma
Brinkhoff et al. Microsphere priming facilitates induction of potent therapeutic T‐cell immune responses against autochthonous liver cancers
JP2022501046A (ja) アルギナーゼ1ポリペプチド
CN104341530A (zh) Vnsak多肽及其应用
JP2023522193A5 (cg-RX-API-DMAC7.html)
Huang et al. Reprogramming the genome of M13 bacteriophage for all-in-one personalized cancer vaccine
Schadendorf Gene-based therapy of malignant melanoma